This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Jado Technologies Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. , Technische Universitát Dresden. Active years: 2009.
Company Filing History:
1 out of 3 
1 out of 1,330 
1 out of 100 
Years Active: 2009
Title: Cornelia Schroeder: Innovator in Sphingolipid-Derived Pharmaceutical Compositions
Introduction
Cornelia Schroeder is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceutical compositions, particularly focusing on sphingolipids and their derivatives. Her innovative work aims to address various medical disorders related to lipid rafts.
Latest Patents
Cornelia Schroeder holds a patent for "Sphingolipid-derived pharmaceutical compositions." This invention relates to specific sphingolipids and sphingolipid derivatives that can be utilized in the preparation of medicaments. The compositions are designed for the treatment, prevention, and amelioration of disorders associated with pathological processes in lipid rafts. She has 1 patent to her name.
Career Highlights
Throughout her career, Cornelia has worked with esteemed organizations such as the Max Planck Society for the Advancement of Science and Technische Universität Dresden. Her experience in these institutions has allowed her to develop her expertise in pharmaceutical research and innovation.
Collaborations
Cornelia has collaborated with notable colleagues, including Tobias Braxmeier and Tim Friedrichson. These partnerships have contributed to her research and the advancement of her inventions.
Conclusion
Cornelia Schroeder's work in sphingolipid-derived pharmaceutical compositions showcases her dedication to advancing medical science. Her innovative contributions continue to impact the field positively.